What determines the cost of BioBran MGN-3?
Although BioBran is “merely” pre-digested rice bran that has been fractionated to select certain molecular sizes, the process itself is quite complex to do under pharmaceutically controlled conditions. Also, the yield of BioBran from rice bran during this process is actually very small. This makes BioBran an expensive product. Add to this the product development and research costs that Daiwa Pharmaceutical have borne over the years and you begin to understand the costs involved. In the future, this price will gradually reduce as development costs are recouped, hospitals carry a larger percentage of the research costs, and production is scaled up.
